Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovary

Objective: Novel treatment strategies are needed for patients with anaplastic carcinoma of the ovary given the high incidence of chemoresistance to conventional systemic therapies. Here we sought to evaluate HER2, FOLR1, TROP2, and mismatch repair protein expression as well as the tumor mutational b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mackenzie W. Sullivan, M. Herman Chui, Alexa N. Kanbergs, Hunter Green, Kaitlyn Gill, Pier Selenica, Achim A. Jungbluth, Kara C. Long, Yukio Sonoda, Jennifer J. Mueller, Christopher Tarney, Rachel N. Grisham, Vicky Makker, Nadeem R. Abu-Rustum, Britta Weigelt, Roisín E. O’Cearbhaill
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-04-01
Colecção:	Gynecologic Oncology Reports
Assuntos:	Ovarian cancer Anaplastic Mucinous Mural nodule Antibody–drug conjugate
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352578926000445
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!